Dysmegakaryopoiesis and Transient Mild Increase in Bone Marrow Blasts in Patients With Aplastic Anemia Treated With Eltrombopag May Be Signs of Hematologic Improvement and Not Portend Clonal Evolution.

Patients in whom the treatment was assessed as effective (achieved CR/partial response or showed a trend of hematologic improvement) at week 26 entered the extension phase to continue treatment until the product became commercially available Figure 1B .

also in 53,322 other papers